| Issue |
Section |
Title |
File |
| Vol 23, No 4 (2021) |
ORIGINAL ARTICLE |
The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment |
(Rus)
|
| Vol 23, No 5 (2021) |
ORIGINAL ARTICLE |
Evaluation of bovhyaluronidase azoxymer efficacy in combined treatment of patients with endometriosis based on the results of multicenter prospective non-interventional study (ISLAND) |
(Rus)
|
| Vol 23, No 5 (2021) |
CLINICAL CASE |
Effectiveness of treatment of the Asherman’s syndrome in women of reproductive age. Case report |
(Rus)
|
| Vol 23, No 6 (2021) |
REVIEW |
Anti-adhesive barriers in clinical practice: personalized patient management |
(Rus)
|
| Vol 23, No 6 (2021) |
LECTURE |
Pathogenesis of vaginal prolapse with the formation of rectocele: a review |
(Rus)
|
| Vol 23, No 6 (2021) |
BEST PRACTICE |
Possibilities of drug therapy for uterine leiomyoma in reproductive age |
(Rus)
|
| Vol 24, No 5 (2022) |
REVIEW |
Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life |
(Rus)
|
| Vol 24, No 4 (2022) |
BEST PRACTICE |
Effectiveness of alternative GSM therapies: "twist of fate" or natural evolution? |
(Rus)
|
| Vol 24, No 5 (2022) |
ORIGINAL ARTICLE |
A clinical and immunological rationale for ultrasonic cavitation use in the complex treatment of infertility in chronic endometritis |
(Rus)
|
| Vol 24, No 6 (2022) |
REVIEW |
Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review |
(Rus)
|
| Vol 25, No 1 (2023) |
BEST PRACTICE |
Extrapelvic endometriosis: the mystery of the "black square" or "quintessential classics"? |
(Rus)
|
| Vol 25, No 2 (2023) |
ORIGINAL ARTICLE |
Efficacy and safety of non-hormonal agents for vasomotor symptoms of menopause: A prospective, double-blind, placebo-controlled study |
(Rus)
|
| Vol 25, No 4 (2023) |
REVIEW |
Metabesity: pathogenetic bases and predictive capabilities. A review |
(Rus)
|
| Vol 27, No 1 (2025) |
REVIEW |
"Neutrality in everything," or "endocrine-metabolic nocturne" of the combined oral contraceptive based on E4/drospirenone: A review |
(Rus)
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).